Skip to content
River Logic

Case study · Life sciences

A 2% cut in cost of goods, with analysis in days instead of weeks

2%lower COGS

  • Life sciences
  • Sourcing

About

A global biopharmaceutical company that develops and markets innovative drugs, relying heavily on contract manufacturers and under pressure from drug-price negotiations and tariffs.

01

Long-range planning left out contracts and financials. Planning, sourcing and finance weren't aligned, and scenarios took a lot of manual work across spreadsheets and fragmented tools that were prone to data errors.

02

The pharma and bio manufacturing network in EO Decision Engine with regulatory, supplier contract, capacity and financial constraints, set to minimize cost. Contract terms and renewals are part of the model, along with demand swings, new product launches and supply disruptions.

03

A 2% reduction in cost of goods sold. Analysis run time went from weeks to days, scenario preparation hours fell by half, and business users now run their own scenarios instead of waiting on specialists.

Customers and partners

  • Merck
  • PwC
  • Accenture
  • Microsoft
  • Gurobi
  • Kenvue
  • Georgia-Pacific
  • Bristol Myers Squibb
  • Tronox
  • ToolsGroup
  • ZS
  • McKee Foods
  • Philip Morris International
  • Yorkshire Water
  • Brookes
  • AlixPartners
  • Finstock
  • BMA
  • Tengler
  • Transnova
  • Cornerstone
  • Tarmac
  • Boise